TARGET: Difference between revisions

Jump to navigation Jump to search
(Redirecting 'TARGET' to 'Comparison Of Two Platelet Glycoprotein IIb/IIia Inhibitors, Tirofiban And Abciximab, For The Prevention Of Ischemic Events With Percutaneous Coronary Revascularization')
 
(No difference)

Latest revision as of 19:20, 6 July 2009